TBIO
TELESIS BIO INC by Telesis Bio, Inc. (TBIO)
$00
About TELESIS BIO INC by Telesis Bio, Inc. (TBIO)
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.55
52 Week Low
$0.00
Market cap
235,200
Dividend yield
0.00%
Volume
4
Avg. volume
361
P/E ratio
.00
TELESIS BIO INC by Telesis Bio, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.55
52 Week Low
$0.00
Market cap
235,200
Dividend yield
0.00%
Volume
4
Avg. volume
361
P/E ratio
.00